Na Shen - Concepedia

Author

Na Shen

Chinese Academy of Sciences ORCID

Also Known As

N Shen, N. Shen, Na Shen, Shen Na, Shen, Na

114

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Sciences Changchun Institute of Applied Chemistry Jilin University Hormel (United States)University of Minnesota

About

Na Shen is an author at Chinese Academy of Sciences specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	864
2	Engineering	8	8	316
3	Natural Sciences	3	3	164
4	Biochemistry	2	2	50
5	Health Sciences	1	1	60

Na Shen

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia‐Activated Prodrug Tirapazamine Therapy for Metastatic Tumors Shengcai Yang, Zhaohui Tang, Chenyang Hu, Advanced Materials	2019	212
CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling Xiaolin Wan, Na Shen, Arnulfo Mendoza, Neoplasia	2006	146
Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug Jian Jiang, Na Shen, Tianyuan Ci, Advanced Materials Mmp9-dox-nps ExhibitsTumor Hypoxia StateOncologyNanotherapeuticsDoxorubicin Prodrug	2019	111
Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation Fei Yan, Na Shen, Jiayun Pang, Cell Death and Disease	2014	107
Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy Rong Deng, Na Shen, Yang Yang, Biomaterials NanomedicineDrug TargetingEngineeringEpigenetic PathwayNano-drug Delivery	2018	106
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells Fei Yan, Na Shen, Jiayun Pang, Leukemia ChromatinMetabolic SyndromeNatural SciencesEpigenetic ChangeEpigenomics	2016	98
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation Xuefeng Gao, Fei Yan, Jiang Lin, Leukemia Tumor BiologyCell RegulationMedicineDnmt3a TransactivationCell Biology	2015	96
Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment Na Shen, Jing Wu, Chenguang Yang, Nano Letters	2019	81
Hypoxia-sensitive supramolecular nanogels for the cytosolic delivery of ribonuclease A as a breast cancer therapeutic Xinghui Si, Sheng Ma, Yudi Xu, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineEngineeringHypoxia-sensitive Supramolecular NanogelsPolymer-drug Conjugate	2020	76
PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(<scp>l</scp>‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer Hanjiao Qin, Haiyang Yu, Jiyao Sheng, Advanced Science	2019	72

Page 1